This talk was presented at the 2018 SAGES Meeting/16th World Congress of Endoscopic Surgery by Tonia M Young-Fadok during the Postgraduate Course: Total Mesorectal Excision – Optimizing Surgery and Managing Challenges on April 11 2018
Keyword(s): 5-HT3 receptor antagonists, atrophy, bloating, bowel movements, chemotherapy, classification, colorectal cancer, denervation, diagnosis, diarrhea, dietary restriction, dissection, diversion, diverting stoma, failure, fecal diversion, fiber, frequency, incontinence, irritable bowel syndrome, LARS, Loperamide, low anastomosis, low anterior resection syndrome, medication, mitigation, neoadjuvant radiation, Neomycin, neurostimulation, partial mesorectal excision, pathophysiology, pelvic floor dysfunction, pelvic floor rehabilitation, post-op LAR syndrome, post-prandial urgency, postoperative LAR syndrome, prevention, probiotics, radiation, Ramosetron, rectum, retention enema, retrospective study, Rifaxamin, sacral nerve stimulation, Simethicone, SNS, sphincter injury, sphincter sparing surgery, stoma nurse, symptoms, TME, total mesorectal excision, transanal irrigation, urgency
LAR syndrome–52 sec
Common symptoms–1:15
Risk factors–1:29
Pathophysiology–1:58
Colonic dysmotility–2:10
Neorectal reservoir dysfunction–2:34
Anal sphincter dyfunction–3:14
Diagnosis–3:26
Evaluation–4:07
Questionnaires–4:28
Treatment–5:06
Minor LARS–5:32 World J Gatroenterol 2014
Major LARS–7:16 Colorectal Dis 2011
Summary–11:38